Physician profile
Jodi E Star
NPI 1184718504
$16,407.41
in general payments reported to CMS, 2019-2025
31 companies · $726 in 2025
The $726 reported for 2025 was more than what 76% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,195 · 2020: $1,534 · 2021: $1,624 · 2022: $1,782 · 2023: $7,828 · 2024: $1,719 · 2025: $726.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,645 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,625 · Travel and Lodging: $997 · Education: $5.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,645.49 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,625.00 |
| Travel and Lodging | $996.98 |
| Education | $5.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $6,383.04 | 2021-2025 | Qelbree, Qelbree |
| Otsuka America Pharmaceutical, INC. | $1,987.57 | 2019-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Takeda Pharmaceuticals U.S.A., INC. | $1,290.55 | 2019-2025 | Trintellix |
| Corium, LLC | $1,099.95 | 2021-2025 | Azstarys |
| Bausch Health US, LLC | $1,030.08 | 2019-2024 | Aplenzin |
| Lundbeck LLC | $863.27 | 2019-2025 | Rexulti |
| Tris Pharma INC | $659.14 | 2019-2025 | Dyanavel Xr |
| Abbvie INC. | $608.69 | 2021-2025 | Vraylar |
| Ironshore Pharmaceuticals INC. | $439.96 | 2019-2024 | Jornay Pm |
| Neos Therapeutics, LP | $216.36 | 2019-2025 | Adzenys Xr-Odt |
| Adlon Therapeutics L.P. | $207.65 | 2019-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $192.05 | 2022-2024 | Caplyta |
| Allergan, INC. | $155.34 | 2019-2020 | |
| Eisai INC. | $139.13 | 2020-2022 | |
| Shire North American Group INC | $133.68 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $121.33 | 2021-2025 | Lybalvi |
| Janssen Pharmaceuticals, INC | $118.77 | 2019-2023 | Spravato |
| Sunovion Pharmaceuticals INC. | $111.35 | 2020-2022 | |
| Idorsia Pharmaceuticals US INC | $102.45 | 2022-2024 | Quviviq |
| Axsome Therapeutics, INC. | $88.07 | 2022-2025 | Auvelity |
| Teva Pharmaceuticals USA, INC. | $87.95 | 2020 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $87.34 | 2025 | |
| Vanda Pharmaceuticals INC. | $66.76 | 2025 | Fanapt |
| Almatica Pharma LLC | $51.46 | 2023-2024 | Loreev Xr, Sertraline Hcl |
| Sentynl Therapeutics, INC. | $40.00 | 2022 | |
| Noven Therapeutics, LLC | $37.29 | 2020-2024 | Xelstrym, Secuado |
| Collegium Pharmaceutical, INC. | $22.98 | 2025 | Jornay Pm |
| Alfasigma USA, INC. | $18.93 | 2020 | |
| Kvk-Tech, INC. | $17.58 | 2019 | |
| Rhodes Pharmaceuticals L.P. | $16.33 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jodi Star listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.